Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to 0.08.

  • Outlook Therapeutics' Asset Utilization Ratio rose 20439.35% to 0.08 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.08, marking a year-over-year increase of 20439.35%. This contributed to the annual value of 0.41 for FY2019, which is 18792.5% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Asset Utilization Ratio of 0.08 as of Q4 2025, which was up 20439.35% from 0.07 recorded in Q3 2025.
  • Outlook Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.08 during Q4 2025, with a 5-year trough of 0.07 in Q4 2024.